Sales tax, that's how it is, says Abihpec

The President of the Brazilian Association of the industry of personal hygiene, perfumery and cosmetics (Abihpec), Joao Carlos Basilio, said yesterday the value that there is no study in the Government to increase tax collections in the industry.
Basilio was yesterday in Brasilia, accompanied by executives from major industries-Natura, Avon, Apothecary, Unilever, P&G, L ' Oréal, Colgate-Palmolive, Johnson and Johnson & Hypermarcas. The delegation met with the future Minister of development, industry and foreign trade (Mdic), Senator Armando Monteiro (PTB-PE), and featured industry data, whose consumer sales totaled r $ 91.6 billion in 2013.
The executives didn't get an audience with the Executive Secretary of the farm, Paul Caffarelli, but Basilio account that received a phone call from him when he was already at the airport. "The [Paul] Cafarelli said that no studies and that can go from quiet year," said Basilio. "There is no guarantee that this subject never surfaced in the new Government, but we won't be caught by surprise."
In February, the value reported that the Government was studying extend to distributors of cosmetics the levying of PIS/Cofins, today restricted to manufacturers. Large companies in the sector constituted different companies for distribution and manufacturing, which had been challenged by the IRS.
The Government suspended the plan in March and promised to find the sector before resuming the analysis. The newspaper "Folha de s. Paulo" reported, the first, that the Government would have to study the case, which surprised the Abihpec.
"We found that penalizing an industry that has shown high growth rates would go in the opposite direction in the interest of the country itself," said yesterday the President Value of Natura, Roberto Lima, before the denial of Government. The Executive didn't comment on what would be the effect of the tax change to Natura. Goldman Sachs calculates that the impact would be of a 57% indentation in the company's earnings per share, according to a report released on Monday, he considered that the rate for the tax would be maintained.
Last week the President Hypermarcas, Claudio Bergamo, said that only 15 percent of the company's revenue would be impacted by such a measure. Most of the company's business is in the pharmaceutical sector.